Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
Authors
Keywords
Hematopoietic stem cell transplantation, Post-transplantation cyclophosphamide, Stem cell source, Acute leukemia, Acute graft-versus-host disease
Journal
Journal of Hematology & Oncology
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-15
DOI
10.1186/s13045-018-0586-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
- (2017) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
- (2016) Ivan S. Moiseev et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation
- (2016) M. Mielcarek et al. BLOOD
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
- (2016) Nicolaus Kröger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease
- (2015) Kenneth F. Bradstock et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies
- (2015) Amin M. Alousi et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission
- (2015) A Ruggeri et al. BONE MARROW TRANSPLANTATION
- OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation
- (2015) Udo Holtick et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
- (2014) C. G. Kanakry et al. BLOOD
- Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Leukemia
- (2014) M. Boyiadzis et al. CLINICAL CANCER RESEARCH
- Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
- (2014) Christopher G. Kanakry et al. JOURNAL OF CLINICAL ONCOLOGY
- Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide
- (2013) C. G. Kanakry et al. Science Translational Medicine
- Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies
- (2012) P. Di Bartolomeo et al. BLOOD
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- Risk factors for acute GVHD and survival after hematopoietic cell transplantation
- (2011) M. Jagasia et al. BLOOD
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
- (2010) L. Luznik et al. BLOOD
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started